Oragenics(GB:0A64)
$5.130.00 (0.00%)
GB:0A64
Oragenics financials statements
$5.13
At close:0.00 (0.00%)
Oragenics (0A64) Income Statement
1 Followers
Oragenics Income Statement
Last quarter (Q3 2026), Oragenics's total revenue was $0.00. In Q3, Oragenics's net income was $-2.60M. See Oragenics’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | |
| $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | |
| $ 9.36M | $ 10.56M | $ 20.90M | $ 14.42M | $ 15.77M | |
| Depreciation and Amortization | $ 0.00 | $ 0.00 | $ 27.39K | $ 44.67K | $ 41.24K |
| $ -9.19M | $ -10.54M | $ -20.60M | $ -14.23M | $ -15.65M | |
| $ -9.36M | $ -10.56M | $ -20.90M | $ -14.42M | $ -15.77M | |
| $ -616.89K | $ -9.10K | $ 249.17K | $ 132.38K | $ 59.40K | |
| $ -9.98M | $ -10.57M | $ -20.66M | $ -14.29M | $ -15.71M | |
| $ -9.84M | $ -10.57M | $ -20.66M | $ -14.29M | $ -15.71M | |
| Per Share Metrics | |||||
| Basic EPS | $ -4.56 | $ -1.60 | $ -9.18 | $ -7.11 | $ -8.09 |
| Diluted EPS | $ -4.56 | $ -1.60 | $ -9.18 | $ -7.11 | $ -8.09 |
| Weighted Average Shares Outstanding | 2.16M | 6.62M | 2.25M | 2.01M | 1.88M |
| Weighted Average Shares Outstanding (Diluted) | 2.16M | 6.62M | 2.25M | 2.01M | 1.88M |
Currency in USD

